Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05645991 · ClinicalTrials.gov registry record · NA

Coconut Sugar Lowers Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

A NA study of Aging and Blood Pressure, sponsored by Ball State University.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT05645991: Completed NA study of Aging and Blood Pressure, sponsored by Ball State University.

NCT05645991 is a NA study of Aging and Blood Pressure that has completed, run by Ball State University. The registered enrollment target is 22 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05645991, a NA study of Aging and Blood Pressure, has completed, sponsored by Ball State University.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The goal of this intervention is to determine the efficacy of coconut sap powder (CSP) to lower arterial stiffness and blood pressure in middle-aged and older adults. Participants will be randomized to the CSP arm or Placebo arm of the study. Primary endpoints include: aortic stiffness assessed by carotid-femoral pulse wave velocity, resting brachial and (non-invasive) carotid blood pressure, and carotid stiffness (e.g. Beta stiffness index, Carotid compliance, Elastic modulus, Distensibility).

Primary Outcome

Carotid-femoral pulse wave velocity (meters/second)

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Coconut Sap Powder (CSP)

Study Locations (1)

Indiana

  • Ball State University - Muncie

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2018-03-08
Est. Completion 2022-01-20
Phase NA
Ball State University

12 total trials

What the finished NCT05645991 record still lists

NCT05645991 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05645991 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT05645991 about?

NCT05645991 is a clinical study titled "Coconut Sugar Lowers Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults". The goal of this intervention is to determine the efficacy of coconut sap powder (CSP) to lower arterial stiffness and blood pressure in middle-aged and older adults. Participants will be randomized to the CSP arm or Placebo arm of the study. Primary endpoints include: aortic stiffness assessed by c...

What is the current status of trial NCT05645991?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2018-03-08. Estimated completion is 2022-01-20.

What conditions does trial NCT05645991 study?

This clinical trial studies the following conditions: Aging, Blood Pressure, Arterial Stiffness.

What interventions are being tested in trial NCT05645991?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Coconut Sap Powder (CSP) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05645991?

This trial is sponsored by Ball State University, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05645991 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05645991's enrollment target sits among peer trials

22 226th of 262 higher than 33 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05645991, the US trial registry maintained by the National Library of Medicine. NCT05645991 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.